Deferoxamine deconditioning increases neuronal vulnerability to hemoglobin.
Sign Up to like & getrecommendations! Published in 2020 at "Experimental cell research"
DOI: 10.1016/j.yexcr.2020.111926
Abstract: Concomitant treatment with deferoxamine (DFO) protects neural cells from iron and heme-mediated oxidative injury, but also disrupts cell responses to iron loading that may be protective. We hypothesized that DFO treatment and withdrawal would subsequently… read more here.
Keywords: hemoglobin; heme; deferoxamine; vulnerability hemoglobin ... See more keywords